Drug Price Controversy
-
Drug maker Valeant sees stock plunge 30%, trading haltedTrading in Valeant Pharmaceutical shares was briefly halted today on the Toronto Stock Exchange as its stock fell 30 per cent in morning trading.CanadaOct 21, 2015
-
Drug maker Valeant expects higher profits despite U.S. pricing probeQuebec-based pharmaceutical giant says 2015 is shaping up to be more profitable than it thought, even as it undergoes scrutiny for dramatic price hikes.ConsumerOct 19, 2015
Trending
-
Anne Heche’s estate cannot pay over $8M in debts, son says18,631 Read
-
Canadian man dies during Texas Ironman event. His widow wants answers as to why10,576 Read
-
B.C. teen’s killer says new TV show about Reena Virk’s murder ‘disrespectful’10,220 Read
-
What is a halal mortgage? How interest-free home financing works in Canada6,526 Read
-
Canada refused to repatriate woman from ISIS camp because she can’t be arrested: internal memo4,810 Read
-
Four injured after military horses break loose, stampede in London, U.K.3,741 Read
-